CareDx (CDNA) Tops Q2 EPS by 9c

CareDx (NASDAQ: CDNA) reported Q2 EPS of $0.11, $0.09 better than the analyst estimate of $0.02. Revenue for the quarter came in at $74.2 million versus the consensus estimate of $67.55 million.

GUIDANCE:

CareDx sees FY2021 revenue of $280-290 million, versus the consensus of $278.4 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Evercore ISI Starts Credo Tech (CRDO) at Outperform
• CRH agrees to buy Arcosa in $8.5B all-cash deal